Telix Pharmaceuticals Limited American (TLX) Dividend Analysis
This company has no dividend history.
Based on TTM and annual data · Not a buy/sell signal
This company does not pay dividends
No dividend history found in company filings.
Does Telix Pharmaceuticals Limited American (TLX) pay a dividend?
Telix Pharmaceuticals Limited American (TLX) has never paid a dividend. Free cash flow is currently negative, so there is no surplus to distribute. All figures are computed from company filings; this is analysis, not investment advice.
Frequently asked
Does Telix Pharmaceuticals Limited American (TLX) pay a dividend?+
No. Telix Pharmaceuticals Limited American (TLX) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold.
How does Telix Pharmaceuticals Limited American return cash to shareholders?+
It largely does not. Telix Pharmaceuticals Limited American pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.
Could Telix Pharmaceuticals Limited American afford to pay a dividend?+
Not currently. Telix Pharmaceuticals Limited American's free cash flow is negative at -$61 million, meaning the business consumed cash over the period rather than generating it. A company funding a dividend from cash it is not producing would be paying shareholders out of its balance sheet or borrowings, which is not sustainable.
Which healthcare companies do pay dividends?+
Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Telix Pharmaceuticals Limited American.
Related stocks: Biotechnology
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.